Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02100189 · ClinicalTrials.gov registry record · NA

Esophageal Cytology With FISH in Detecting Esophageal Cancer

A NA study of Weight Loss and Esophageal Adenocarcinoma, sponsored by OHSU Knight Cancer Institute.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT02100189 is a NA study of Weight Loss and Esophageal Adenocarcinoma that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 50 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02100189, a NA study of Weight Loss and Esophageal Adenocarcinoma, has completed, sponsored by OHSU Knight Cancer Institute.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies whether esophageal cytology plus fluorescence in situ hybridization (FISH) is equal to or better than esophago-gastro-duodenoscopy (EGD) or upper endoscopy for the early detection of esophageal cancer. Genes are the units of deoxyribonucleic acid (DNA) the chemical structure carrying genetic information that determine many human characteristics. Certain genes in cancer cells may determine how the tumor grows or spreads and how it may respond to different drugs. Part of this study is to test those genes in esophageal cells using FISH.

Interventions

  • OTHER Laboratory Biomarker Analysis
  • OTHER Cytology Specimen Collection Procedure
  • PROCEDURE Esophagogastroduodenoscopy

Study Locations (1)

Oregon

  • OHSU Knight Cancer Institute - Portland

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2014-02
Est. Completion 2015-12
Phase NA

Sponsor

OHSU Knight Cancer Institute

211 total trials

What the Registry Record Tells You About NCT02100189

The ClinicalTrials.gov registry entry for NCT02100189 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower). The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Weight Loss appearing as the primary indexed condition, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.

NCT02100189 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT02100189 about?

NCT02100189 is a clinical study titled "Esophageal Cytology With FISH in Detecting Esophageal Cancer". This clinical trial studies whether esophageal cytology plus fluorescence in situ hybridization (FISH) is equal to or better than esophago-gastro-duodenoscopy (EGD) or upper endoscopy for the early detection of esophageal cancer. Genes are the units of deoxyribonucleic acid (DNA) the chemical struct...

What is the current status of trial NCT02100189?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-02. Estimated completion is 2015-12.

What conditions does trial NCT02100189 study?

This clinical trial studies the following conditions: Weight Loss, Esophageal Adenocarcinoma, Dysphagia, Gastroesophageal Reflux Disease, Esophageal Squamous Cell Carcinoma.

What interventions are being tested in trial NCT02100189?

The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Cytology Specimen Collection Procedure (OTHER), Esophagogastroduodenoscopy (PROCEDURE).

Who is sponsoring clinical trial NCT02100189?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02100189 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.